Relieving suffering and inflammation – how can this be achieved?

Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling the problem of diagnostic latency is to increase awareness and improve interdisciplinary networking. The evidence base and treatment options have expanded considerably in recent times. In the case of biologics, there are now several active substances to choose from and there have also been some innovations in antibiotics.